Insider Transactions in Q4 2023 at Replimune Group, Inc. (REPL)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 16
2023
|
Christopher Sarchi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,255
-6.78%
|
$52,550
$10.92 P/Share
|
Nov 16
2023
|
Konstantinos Xynos Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,313
-6.09%
|
$73,130
$10.92 P/Share
|